- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
ASHP Midyear Clinical Meeting & Exhibition Returns to Las Vegas
Because of the COVID-19 pandemic, the last 2 years have been virtual; the organization previously met in Las Vegas in 2019 and 2016.
More than 20,000 professionals from the world of pharmacy return to Las Vegas, Nevada, this weekend for the American Society of Health-System Pharmacists (ASHP) 2022 Midyear Clinical Meeting & Exposition.
Because of the COVID-19 pandemic, the last 2 years have been virtual; the organization previously met in Las Vegas in 2019 and 2016.
Running until Thursday, November 8, the meeting features dozens of topics spanning clinical topics and therapeutics, specialty pharmacy, biosimilars, emergency medicine, infectious diseases, technology, home care, and more.
In addition, many sessions zero in on topics that deal heavily with the day-to-day lives of pharmacists and others working in the current health care climate, such as:
- Well-being
- Resiliance
- Leadership
- Burnout
- Transitions
Another track focuses on various topics related to diversity, equity, and inclusion. Sessions encompass supporting those who identify as lesbian, gay, bisexual, transgender, or queer; patients who are disabled; communication strategies for more inclusive work environments; and the dangers of oversimplifying race in clinical practice.
During the meeting, Angela M. Hill, PharmD, CPh, RPh, professor and associate dean of clinical affairs; project director, WE-CARE, University of South Florida Taneja College of Pharmacy, will receive a joint leadership award from ASHP as well as the Association for Black Health-System Pharmacists for her work in addressing health equities.
Another award is being given to Marie A. Chisholm-Burns, PharmD, PhD, MPH, MBA, FCCP, FASHP, FAST, executive vice president and provost at Oregon Health and Science University. She will receive the ASHP Board of Directors’ Distinguished Leadership Award for her work in pharmacy practice leadership and academic pharmacy.
Integrating RECIST and Clinician Approaches Boosts NSCLC Research
May 8th 2024Outcomes among patients with stage IV non–small cell lung cancer as evaluated within clinical trials via Response Evaluation Criteria in Solid Tumors (RECIST) and clinician response criteria in observational studies were compared for their concordance and reliability.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Budesonide-Based Triple Therapy Shows Best Benefit Over Dual Therapy for COPD
May 8th 2024The triple therapy of budesonide, glycopyrrolate, and formoterol fumarate showed the greatest incremental net benefit among a series of triple therapy medications that were evaluated against dual therapy for chronic obstructive pulmonary disease (COPD), according to an analysis presented at ISPOR.
Read More
